Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


11.09.2017

2 Am J Gastroenterol
1 Am J Med
1 Arch Virol
3 Dig Dis Sci
3 Eur J Gastroenterol Hepatol
2 Gastroenterology
4 Hepatology
4 J Hepatol
9 J Med Virol
1 J Virol
1 JAMA
6 PLoS One
1 Transplantation
1 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Gastroenterol

  1. HUANG R, Yan X, Liu Y, Zhang Z, et al
    Can Transient Elastography Predict Fibrosis Regression in Patients with Chronic Hepatitis B During Long-Term Antiviral Therapy?
    Am J Gastroenterol. 2017;112:1477-1478.
    PubMed     Text format    

  2. KOFF RS
    Editorial: Direct Antiviral Agents Eliminate the Age Barrier to Treatment of Chronic Hepatitis C.
    Am J Gastroenterol. 2017;112:1410-1411.
    PubMed     Text format     Abstract available


    Am J Med

  3. REZANIA K, Pytel P, Derani L, Greenwald R, et al
    A Masked Marauder: Hepatitis C Neuropathy.
    Am J Med. 2017 Sep 4. pii: S0002-9343(17)30893.
    PubMed     Text format    


    Arch Virol

  4. PONDE RAA
    The serological markers of acute infection with hepatitis A, B, C, D, E and G viruses revisited.
    Arch Virol. 2017 Sep 7. doi: 10.1007/s00705-017-3538.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  5. IKEDA K, Kawamura Y, Kobayashi M, Kominami Y, et al
    Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Sep 7. doi: 10.1007/s10620-017-4739.
    PubMed     Text format     Abstract available

  6. PURNAK T, Efe C, Kav T, Wahlin S, et al
    Treatment Response and Outcome with Two Different Prednisolone Regimens in Autoimmune Hepatitis.
    Dig Dis Sci. 2017 Sep 4. doi: 10.1007/s10620-017-4728.
    PubMed     Text format     Abstract available

  7. DU JEONG I, Jung SW, Park BR, Lee BU, et al
    Clinical Course of Partial Virologic Response with Prolonged Tenofovir Therapy in Nuclos(t)ides-Naive Patients with Chronic Hepatitis B.
    Dig Dis Sci. 2017 Sep 4. doi: 10.1007/s10620-017-4737.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  8. MILAZZO L, Magni C, Niero F, Schiavini M, et al
    Retreatment of chronic hepatitis C virus infection after unsuccessful therapy with all-oral direct-acting antiviral regimens: a real-life experience.
    Eur J Gastroenterol Hepatol. 2017 Sep 4. doi: 10.1097/MEG.0000000000000965.
    PubMed     Text format     Abstract available

  9. FAN Y, Cao W, Di H, Liu C, et al
    Assessment of liver fibrosis with acoustic radiation force impulse in patients with chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2017;29:1190.
    PubMed     Text format    

  10. LANG S, Kutting F, Staub A, Schramowski J, et al
    Performance of simple noninvasive scoring systems for the prediction of advanced fibrosis in patients with chronic hepatitis B.
    Eur J Gastroenterol Hepatol. 2017 Sep 6. doi: 10.1097/MEG.0000000000000977.
    PubMed     Text format     Abstract available


    Gastroenterology

  11. CHILDS-KEAN LM, Hong J
    Detectable Viremia at the End of Treatment With Direct-Acting Antivirals Can Be Associated With Subsequent Clinical Cure in Patients With Chronic Hepatitis C: A Case Series.
    Gastroenterology. 2017 Sep 4. pii: S0016-5085(17)35912.
    PubMed     Text format    

  12. MAAN R, Feld JJ
    Risk for hepatocellular carcinoma after HCV antiviral therapy with direct-acting antivirals: case closed?
    Gastroenterology. 2017 Aug 31. pii: S0016-5085(17)36085.
    PubMed     Text format    


    Hepatology

  13. ALTER H, Block TM, Brown N, Brownstein A, et al
    A Research Agenda for Curing Chronic Hepatitis B Virus Infection.
    Hepatology. 2017 Sep 6. doi: 10.1002/hep.29509.
    PubMed     Text format    

  14. BORENTAIN P, Colson P, Bolon E, Gauchez P, et al
    Hepatocellular carcinoma complicating hepatitis E virus-related cirrhosis.
    Hepatology. 2017 Sep 5. doi: 10.1002/hep.29508.
    PubMed     Text format    

  15. PARK H, Chen C, Wang W, Henry L, et al
    Chronic Hepatitis C Increases the Risk of Chronic Kidney Disease (CKD) while Effective HCV Treatment Decreases the Incidence of CKD.
    Hepatology. 2017 Sep 5. doi: 10.1002/hep.29505.
    PubMed     Text format     Abstract available

  16. TOYODA H, Chayama K, Suzuki F, Sato K, et al
    Efficacy and Safety of Glecaprevir/Pibrentasvir in Japanese Patients with Chronic Genotype 2 Hepatitis C Virus Infection.
    Hepatology. 2017 Sep 2. doi: 10.1002/hep.29510.
    PubMed     Text format     Abstract available


    J Hepatol

  17. CALVARUSO V, Craxi A
    HBV recurrence after HCV clearance on DAAs: Sometimes They Come Back.
    J Hepatol. 2017 Aug 29. pii: S0168-8278(17)32256.
    PubMed     Text format    

  18. YIP TC, Chan HL, Wong VW, Wong GL, et al
    Reply to: "Risk factors of hepatocellular carcinoma after hepatitis B surface antigen seroclearance".
    J Hepatol. 2017 Sep 1. pii: S0168-8278(17)32266.
    PubMed     Text format    

  19. HUANG R, Liu Y, Wang J, Xia J, et al
    Risk factors of hepatocellular carcinoma after hepatitis B surface antigen seroclearance.
    J Hepatol. 2017 Sep 1. pii: S0168-8278(17)32270.
    PubMed     Text format    

  20. KARAMPATOU A, Han X, Kondili LA, Taliani G, et al
    Premature ovarian senescence and high miscarriage rate impair fertility in women with hepatitis C virus infection.
    J Hepatol. 2017 Sep 4. pii: S0168-8278(17)32259.
    PubMed     Text format     Abstract available


    J Med Virol

  21. ZHANG Y, Wang L, Zeng H, Gong W, et al
    Development and validation of a new serum standard for the measurement of anti-HEV antibodies in animals.
    J Med Virol. 2017;89:497-501.
    PubMed     Text format     Abstract available

  22. CICCOZZI M, Chaouch H, Lo Presti A, Taffon S, et al
    Evolutionary dynamics of HBV-D7 subgenotype in Tunisia.
    J Med Virol. 2017;89:469-475.
    PubMed     Text format     Abstract available

  23. JOGEDA EL, Huik K, Pauskar M, Kallas E, et al
    The prevalence and genotypes of GBV-C and its associations with HIV infection among persons who inject drugs in Eastern Europe.
    J Med Virol. 2016 Sep 7. doi: 10.1002/jmv.24683.
    PubMed     Text format     Abstract available

  24. MOBARAK L, Omran D, Nabeel MM, Zakaria Z, et al
    Fibro markers for prediction of hepatocellular carcinoma in Egyptian patients with chronic liver disease.
    J Med Virol. 2017;89:1062-1068.
    PubMed     Text format     Abstract available

  25. KIM MN, Park JY, Ahn SH, Kim BK, et al
    Durability of the virological response after lamivudine discontinuation in lamivudine-resistant patients with a complete virological response after lamivudine and adefovir combination therapy.
    J Med Virol. 2016 Jun 30. doi: 10.1002/jmv.24616.
    PubMed     Text format     Abstract available

  26. SAGNELLI C, Ciccozzi M, Coppola N, Minichini C, et al
    Molecular diversity in irregular or refugee immigrant patients with HBV-genotype-E infection living in the metropolitan area of Naples.
    J Med Virol. 2017;89:1015-1024.
    PubMed     Text format     Abstract available

  27. ZHANG K, Liu Y, Chen R, Li Q, et al
    Antigenicity reduction contributes mostly to poor detectability of HBsAg by hepatitis B virus (HBV) S-gene mutants isolated from individuals with occult HBV infection.
    J Med Virol. 2017 Sep 6. doi: 10.1002/jmv.24936.
    PubMed     Text format     Abstract available

  28. CAVARETTO LDSP, Motta-Castro ARC, Teles SA, de Souza FQ, et al
    Epidemiological and molecular analysis of hepatitis B virus infection in manicurists in Central Brazil.
    J Med Virol. 2017 Sep 8. doi: 10.1002/jmv.24940.
    PubMed     Text format     Abstract available

  29. SCHULZ TR, Edwards R, Thurnheer MC, Yuen L, et al
    Hepatitis B amongst Immigrants from Myanmar: Genotypes and their Clinical Relevance.
    J Med Virol. 2017 Sep 8. doi: 10.1002/jmv.24939.
    PubMed     Text format     Abstract available


    J Virol

  30. NAGASHIMA S, Takahashi M, Kobayashi T, Tanggis, et al
    The characterization of the quasi-enveloped hepatitis E virus particles released by the cellular exosomal pathway.
    J Virol. 2017 Sep 6. pii: JVI.00822-17. doi: 10.1128/JVI.00822.
    PubMed     Text format     Abstract available


    JAMA

  31. VOELKER R
    Combination Drug for HCV Infection.
    JAMA. 2017;318:790.
    PubMed     Text format    


    PLoS One

  32. WANG L, Cao M, Wei QL, Zhao ZH, et al
    A new model mimicking persistent HBV e antigen-negative infection using covalently closed circular DNA in immunocompetent mice.
    PLoS One. 2017;12:e0175992.
    PubMed     Text format     Abstract available

  33. VUTIEN P, Jin M, Le MH, Nguyen P, et al
    Regional differences in treatment rates for patients with chronic hepatitis C infection: Systematic review and meta-analysis.
    PLoS One. 2017;12:e0183851.
    PubMed     Text format     Abstract available

  34. GOMEZ-MORENO AZ, Pineda-Tenor D, Jimenez-Sousa MA, Sanchez-Ruano JJ, et al
    Liver stiffness measurement predicts liver-related events in patients with chronic hepatitis C: A retrospective study.
    PLoS One. 2017;12:e0184404.
    PubMed     Text format     Abstract available

  35. DAVIES J, Li SQ, Tong SY, Baird RW, et al
    Establishing contemporary trends in hepatitis B sero-epidemiology in an Indigenous population.
    PLoS One. 2017;12:e0184082.
    PubMed     Text format     Abstract available

  36. ZHENG Z, Sze CW, Keng CT, Al-Haddawi M, et al
    Hepatitis C virus mediated chronic inflammation and tumorigenesis in the humanised immune system and liver mouse model.
    PLoS One. 2017;12:e0184127.
    PubMed     Text format     Abstract available

  37. GONZALEZ R, De la Rosa AJ, Rufini A, Rodriguez-Hernandez MA, et al
    Role of p63 and p73 isoforms on the cell death in patients with hepatocellular carcinoma submitted to orthotopic liver transplantation.
    PLoS One. 2017;12:e0174326.
    PubMed     Text format     Abstract available


    Transplantation

  38. RADHAKRISHNAN K, Chi A, Quan DJ, Roberts JP, et al
    Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients.
    Transplantation. 2017;101:2079-2082.
    PubMed     Text format     Abstract available


    Vaccine

  39. OKADA Y, Uno N, Sato S, Mori S, et al
    Strong influence of human leukocyte antigen-DP variants on response to hepatitis B vaccine in a Japanese population.
    Vaccine. 2017 Sep 4. pii: S0264-410X(17)31133.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: